Matthew Roughley

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Mild Cognitive Impairment

Chronic Kidney Disease

Top Venues

British journal of clinical pharmacology

Drug and therapeutics bulletin

Arthritis research & therapy

BMJ case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew Roughley, Carlos Mena, Robert Howard, Suzanne J Reeves, Julie Bertrand
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring. British journal of clinical pharmacology (2023)
Matthew Roughley, Carlos Mena, Robert Howard, Suzanne J Reeves, Julie Bertrand
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring. British journal of clinical pharmacology (2023)
Matthew Roughley, Marc Lyall
Republished: Retrograde ejaculation associated with quetiapine and treatment with low-dose imipramine. Drug and therapeutics bulletin 57 (12) (2019)
Matthew Roughley, Marc Lyall
Retrograde ejaculation associated with quetiapine and treatment with low-dose imipramine. BMJ case reports 12 (8) (2019)
Matthew Roughley, Alyshah Abdul Sultan, Lorna Clarson, Sara Muller, Rebecca Whittle, John Belcher, Christian D Mallen, Edward Roddy
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis research & therapy 20 (1) (2018)